<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview of TORCH infections
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview of TORCH infections
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview of TORCH infections
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karen E Johnson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karen M Puopolo, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 29, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infections acquired in utero or during the birth process are a significant cause of fetal and neonatal mortality and an important contributor to early and later childhood morbidity. The infected newborn infant may show abnormal growth, developmental anomalies, or multiple clinical and laboratory abnormalities [
         <a href="#rid1">
          1
         </a>
         ]. The TORCH acronym is well recognized in the field of neonatal/perinatal medicine [
         <a href="#rid2">
          2
         </a>
         ]. It includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Toxoplasmosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Others (syphilis, Zika virus, varicella-zoster virus)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rubella
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cytomegalovirus (CMV)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Herpes simplex virus (HSV)
        </p>
        <p>
        </p>
        <p>
         Other well-described causes of in utero infection include enteroviruses, parvovirus B19, and lymphocytic choriomeningitis virus. Thus, broadening the "other" category to include additional pathogens has been proposed [
         <a href="#rid3">
          3,4
         </a>
         ].
        </p>
        <p>
         An overview of the clinical features of specific TORCH infections and an approach to the infant with suspected intrauterine infection will be provided below. The individual TORCH infections are discussed in more detail separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6756.html" rel="external">
          "Toxoplasmosis and pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15835.html" rel="external">
          "Congenital toxoplasmosis: Treatment, outcome, and prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4794.html" rel="external">
          "Syphilis in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">
          "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15400.html" rel="external">
          "Congenital syphilis: Management and outcome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8331.html" rel="external">
          "Varicella-zoster virus infection in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4969.html" rel="external">
          "Varicella-zoster infection in the newborn"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/109681.html" rel="external">
          "Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8312.html" rel="external">
          "Rubella in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6047.html" rel="external">
          "Congenital rubella"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4810.html" rel="external">
          "Cytomegalovirus infection in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/98188.html" rel="external">
          "Congenital cytomegalovirus infection: Management and outcome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8340.html" rel="external">
          "Genital herpes simplex virus infection and pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6040.html" rel="external">
          "Neonatal herpes simplex virus infection: Management and prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8281.html" rel="external">
          "Parvovirus B19 infection during pregnancy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          SCREENING FOR TORCH INFECTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H1051579872">
         <span class="h2">
          Screening during pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The practice of screening for TORCH infections during pregnancy varies geographically. In the United States, the Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG) recommend that pregnant individuals be screened for rubella and syphilis at the first prenatal visit. In other countries, pregnant individuals also may be screened for toxoplasmosis. Prenatal screening recommendations are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/446.html" rel="external">
          "Prenatal care: Initial assessment", section on 'Standard panel'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1384136305">
         <span class="h2">
          Newborn screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asymptomatic infants generally are not screened for congenital infections, with the following exceptions:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Toxoplasmosis – Some European countries and a few select states in the United States have adopted universal newborn screening for toxoplasmosis [
         <a href="#rid5">
          5-7
         </a>
         ]. This is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis", section on 'Newborn screening'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cytomegalovirus (CMV) – Targeted newborn screening for congenital CMV infection (ie, testing infants who fail the newborn hearing screen) is performed in some states. Universal screening has been proposed, but the most reliable and cost-effective method for screening has not been established, and this practice has not gained widespread adoption. This is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis", section on 'Newborn screening for congenital cytomegalovirus'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Although identification of immunoglobulin M (IgM) antibodies in the newborn is suggestive of congenital infection (because IgM antibodies do not cross the placenta), indiscriminate screening for TORCH infections with a battery of "TORCH titers" is costly and has a poor diagnostic yield [
         <a href="#rid8">
          8-12
         </a>
         ]. Our preferred approach involves testing of infants with suspected congenital infections for specific pathogens based upon their clinical presentation [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="local">
          'Approach to the infant with suspected intrauterine infection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H650131395">
         <span class="h1">
          CLINICAL FEATURES OF TORCH INFECTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Congenital toxoplasmosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Toxoplasmosis is caused by the protozoan parasite
         <em>
          Toxoplasma
         </em>
         <em>
          gondii
         </em>
         . Primary infection during pregnancy can result in congenital disease. (See
         <a class="medical medical_review" href="/z/d/html/6756.html" rel="external">
          "Toxoplasmosis and pregnancy"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Newborn findings
         </strong>
         – Most infants with congenital toxoplasmosis are asymptomatic or without apparent abnormalities at birth. Although subclinical disease is the rule, signs present at birth may include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fever
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Maculopapular rash
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hepatosplenomegaly  (
         <a class="graphic graphic_picture graphicRef71515" href="/z/d/graphic/71515.html" rel="external">
          picture 1
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Microcephaly
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Seizures
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Jaundice
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Thrombocytopenia
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Generalized lymphadenopathy (uncommon)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Late findings
         </strong>
         – Infants with subclinical congenital toxoplasmosis who do not receive treatment have an increased risk of long-term sequelae, which may include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chorioretinitis  (
         <a class="graphic graphic_picture graphicRef80549" href="/z/d/graphic/80549.html" rel="external">
          picture 2
         </a>
         ), which is the most common late finding and can result in vision loss
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intellectual disability
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sensorineural hearing loss (SNHL)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Seizures
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Spasticity/cerebral palsy
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The so-called classic triad of congenital toxoplasmosis consists of chorioretinitis, hydrocephalus, and intracranial calcifications  (
         <a class="graphic graphic_diagnosticimage graphicRef60804" href="/z/d/graphic/60804.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         The diagnosis, management, and prevention of congenital toxoplasmosis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15835.html" rel="external">
          "Congenital toxoplasmosis: Treatment, outcome, and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Congenital syphilis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital syphilis occurs when the spirochete
         <em>
          Treponema
         </em>
         <em>
          pallidum
         </em>
         is transmitted from a pregnant woman to her fetus. Infection can result in stillbirth, hydrops fetalis, or prematurity and associated long-term morbidity. Because of this morbidity, great emphasis has been placed on routine syphilis screening of all pregnant women. (See
         <a class="medical medical_review" href="/z/d/html/4794.html" rel="external">
          "Syphilis in pregnancy", section on 'Maternal screening'
         </a>
         .)
        </p>
        <p>
         The incidence of congenital syphilis reflects the rate of syphilis in women of childbearing age. Many congenital cases develop because the mother received no prenatal care, no penicillin treatment, or inadequate treatment before or during pregnancy.
        </p>
        <p>
         Most neonates with congenital syphilis are asymptomatic at birth. Overt infection can manifest in the fetus, the newborn, or later in childhood. Clinical manifestations after birth are divided arbitrarily into early (≤2 years of age  (
         <a class="graphic graphic_table graphicRef67809" href="/z/d/graphic/67809.html" rel="external">
          table 1
         </a>
         )) and late (&gt;2 years of age  (
         <a class="graphic graphic_table graphicRef81529" href="/z/d/graphic/81529.html" rel="external">
          table 2
         </a>
         )).
        </p>
        <p>
         The diagnosis, management, and prevention of congenital syphilis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">
          "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15400.html" rel="external">
          "Congenital syphilis: Management and outcome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2878955828">
         <span class="h2">
          Congenital varicella syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most cases of congenital varicella syndrome occur in infants whose mothers were infected between 8 and 20 weeks gestation. Characteristic findings in neonates may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cutaneous scars, which may be depressed and pigmented in a dermatomal distribution
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cataracts, chorioretinitis, microphthalmos, nystagmus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypoplastic limbs
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cortical atrophy and seizures
        </p>
        <p>
        </p>
        <p>
         The clinical manifestations and diagnosis of congenital varicella syndrome are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8331.html" rel="external">
          "Varicella-zoster virus infection in pregnancy", section on 'Fetal effects of VZV infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8331.html" rel="external">
          "Varicella-zoster virus infection in pregnancy", section on 'Congenital varicella syndrome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1071779104">
         <span class="h2">
          Congenital Zika syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical manifestations of congenital Zika virus infection vary, ranging from asymptomatic or mild neurodevelopmental abnormalities to severe congenital anomalies (ie, congenital Zika syndrome [CZS]  (
         <a class="graphic graphic_picture graphicRef109690" href="/z/d/graphic/109690.html" rel="external">
          picture 3
         </a>
         )). CZS is characterized by a combination of the following findings  (
         <a class="graphic graphic_table graphicRef110678" href="/z/d/graphic/110678.html" rel="external">
          table 3
         </a>
         ), though affected infants rarely have all of these findings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Microcephaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Craniofacial dysmorphisms (eg, craniofacial disproportion, craniosynostosis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neuromotor abnormalities (eg, hypertonia/spasticity, hyperreflexia, irritability)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Arthrogryposis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ocular abnormalities
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SNHL
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neuroimaging abnormalities (eg, intracranial calcifications, ventriculomegaly)  (
         <a class="graphic graphic_diagnosticimage graphicRef109691 graphicRef109692 graphicRef126225" href="/z/d/graphic/109691.html" rel="external">
          image 2A-C
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         The clinical manifestations and diagnosis of congenital Zika virus infection are reviewed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/109681.html" rel="external">
          "Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h2">
          Congenital rubella
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital rubella syndrome (CRS) is rare in developed countries with established rubella immunization programs. It is no longer endemic in the United States, although a few cases are reported to the National Congenital Rubella Registry each year, usually in infants whose mothers emigrated from countries without rubella immunization programs.
        </p>
        <p>
         Clinical manifestations of CRS include  (
         <a class="graphic graphic_table graphicRef75721" href="/z/d/graphic/75721.html" rel="external">
          table 4
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SNHL
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cataracts
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiac malformations (eg, patent ductus arteriosus, pulmonary stenosis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Microcephaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cataracts
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low birth weight
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Radiolucent bone lesions
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatosplenomegaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Jaundice
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thrombocytopenia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Purpuric skin lesions (classically described as "blueberry muffin" lesions  (
         <a class="graphic graphic_picture graphicRef69581" href="/z/d/graphic/69581.html" rel="external">
          picture 4
         </a>
         ) that represent extramedullary hematopoiesis)
        </p>
        <p>
        </p>
        <p>
         The diagnosis, management, and prevention of CRS are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6047.html" rel="external">
          "Congenital rubella"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H623590887">
         <span class="h2">
          Congenital cytomegalovirus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital cytomegalovirus (CMV) infection is the leading cause of nonhereditary sensorineural hearing loss and can cause other long-term neurodevelopmental disabilities, including cerebral palsy, intellectual disability, vision impairment, and seizures.
        </p>
        <p>
         CMV infection is common worldwide. Despite its listing as the fourth infection in the TORCH designation, CMV has emerged as the most common congenital viral infection. Maternal CMV infection during pregnancy most often results from close contact with young children. Persons who work in childcare centers are at particular risk of infection.
        </p>
        <p>
         At birth, most infants with congenital CMV are asymptomatic, but approximately 10 percent have symptoms. Clinical manifestations of congenital CMV infection may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Isolated SNHL – This is the most common presentation and is typically identified by failed newborn hearing screen
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Petechiae  (
         <a class="graphic graphic_picture graphicRef98822" href="/z/d/graphic/98822.html" rel="external">
          picture 5
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Jaundice at birth
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatosplenomegaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thrombocytopenia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small size for gestational age
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Microcephaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intracranial calcifications  (
         <a class="graphic graphic_diagnosticimage graphicRef98838 graphicRef98839" href="/z/d/graphic/98838.html" rel="external">
          image 3A-B
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chorioretinitis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures
        </p>
        <p>
        </p>
        <p>
         Both asymptomatic and symptomatic infants with congenital CMV are at risk of developing late complications including late-onset SNHL, vision impairment, intellectual disability, and delay in psychomotor development.
        </p>
        <p>
         The diagnosis, management, and prevention of congenital CMV are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/98188.html" rel="external">
          "Congenital cytomegalovirus infection: Management and outcome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4810.html" rel="external">
          "Cytomegalovirus infection in pregnancy", section on 'Strategies for prevention of maternal and/or fetal infection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H39">
         <span class="h2">
          Herpes simplex virus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Genital herpes simplex virus (HSV) infection during pregnancy poses a significant risk to the developing fetus and newborn.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perinatally acquired infection
         </strong>
         – Most cases of neonatal HSV infection are perinatally acquired. HSV is transmitted to an infant during birth, primarily through an infected maternal genital tract. The risk of transmission is greater with primary HSV infection acquired during pregnancy compared with reactivation of previous infection. Among mothers with primary infection, acquisition near the time of labor is the major risk factor for transmission to the neonate. (See
         <a class="medical medical_review" href="/z/d/html/8340.html" rel="external">
          "Genital herpes simplex virus infection and pregnancy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         HSV infection in newborns usually develops in one of three patterns, which occur with roughly equal frequency  (
         <a class="graphic graphic_table graphicRef106132" href="/z/d/graphic/106132.html" rel="external">
          table 5
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Localized to the skin, eyes, and mouth
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Localized central nervous system (CNS) disease
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Disseminated disease involving multiple organs
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The initial manifestations of CNS disease frequently are nonspecific and include temperature abnormality (usually fever, though low temperature can also occur), respiratory distress, poor feeding, and lethargy; they may progress quite rapidly to hypotension, jaundice, disseminated intravascular coagulation, apnea, and shock. Vesicular skin lesions  (
         <a class="graphic graphic_picture graphicRef75059 graphicRef56041 graphicRef78598" href="/z/d/graphic/75059.html" rel="external">
          picture 6A-C
         </a>
         ) may or may not be present and develop late in some patients; the absence of skin lesions complicates recognition of the infection. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital (in utero) infection
         </strong>
         – Intrauterine HSV infection is rare and usually results from maternal viremia associated with primary HSV infection during pregnancy. Live-born infants with congenital HSV infection may exhibit a characteristic triad of skin vesicles, ulcerations, or scarring  (
         <a class="graphic graphic_picture graphicRef55645" href="/z/d/graphic/55645.html" rel="external">
          picture 7
         </a>
         ); eye damage; and severe CNS manifestations, including microcephaly or hydranencephaly. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Intrauterine HSV'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The diagnosis, management, and prevention of neonatal HSV infections are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Evaluation and diagnosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6040.html" rel="external">
          "Neonatal herpes simplex virus infection: Management and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H609355024">
         <span class="h1">
          APPROACH TO THE INFANT WITH SUSPECTED INTRAUTERINE INFECTION
         </span>
        </p>
        <p class="headingAnchor" id="H609355080">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         A high index of suspicion for congenital infection and awareness of the prominent features of the most common congenital infections can help to facilitate early diagnosis and tailor appropriate diagnostic evaluation  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 6
         </a>
         ). For many of the infections discussed in the previous sections, timely diagnosis is crucial to ensure that appropriate therapy is initiated. It also allows for counseling for the parents/caregivers regarding the prognosis, so that an appropriate care plan can be put in place.
        </p>
        <p>
         Our preferred approach to testing infants suspected of having a congenital infection is to test only for select pathogens based upon specific clinical findings  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 6
         </a>
         ) [
         <a href="#rid3">
          3,4
         </a>
         ]. We discourage the practice of indiscriminate screening of infants who have findings compatible with congenital infection with a battery of "TORCH titers" because such an approach is costly and has a poor diagnostic yield [
         <a href="#rid8">
          8,10-14
         </a>
         ]. In addition, the number of pathogens responsible for in utero and perinatal infections continues to expand such that the approach of indiscriminate testing has become challenging. The optimal approach remains uncertain, and practice varies considerably [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H609355087">
         <span class="h2">
          Clinical suspicion
         </span>
         <span class="headingEndMark">
          —
         </span>
         In some cases, intrauterine infection may be suspected on the basis of laboratory results obtained during pregnancy (eg, positive syphilis serology with increasing titers). In the absence of suggestive maternal laboratory results, intrauterine infection may be suspected in newborns with certain clinical manifestations or combinations of clinical manifestations including (but not limited to):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hydrops fetalis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Microcephaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cataract
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sensorineural hearing loss (SNHL)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital heart disease
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatosplenomegaly and jaundice
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rash
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unexplained thrombocytopenia
        </p>
        <p>
        </p>
        <p>
         These findings are not restricted to TORCH infections, and some of the features above may occur in other infections (eg, human parvovirus, Chagas disease [
         <em>
          Trypanosoma cruzi
         </em>
         ]) and in conditions other than intrauterine infection (eg, inborn errors of metabolism, Rh incompatibility, etc). Thus, the entire clinical constellation, including maternal history and exposures, must be taken into account when deciding to evaluate an infant for congenital infection.
        </p>
        <p class="headingAnchor" id="H609355103">
         <span class="h2">
          Initial evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation of a newborn with clinical findings compatible with intrauterine infection varies depending on the specific findings. It may include [
         <a href="#rid16">
          16-18
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Review of maternal history (evidence of rubella immunity, syphilis serology, history of herpes simplex virus [HSV], exposure to cats, etc)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assessment of physical stigmata consistent with various intrauterine infections  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 6
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complete blood count and platelet count
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Liver function tests (particularly important in HSV infection)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Radiographs of long bones
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ophthalmologic evaluation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Audiologic evaluation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neuroimaging
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lumbar puncture
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H609355188">
         <span class="h2">
          Specific evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The results of the initial evaluation may help to determine whether evaluation for a specific pathogen (or pathogens) is warranted. Findings that are more prominent in particular infections are summarized in the table  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 6
         </a>
         ). These may prompt evaluation for a specific pathogen.
        </p>
        <p>
         A few examples of scenarios wherein testing for specific TORCH infections may be warranted include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For newborns who are small for gestational age (SGA) without another identified cause and without other abnormal findings, we generally test for congenital CMV infection and toxoplasmosis. Depending on maternal exposure history, testing for Zika virus infection may also be warranted (Zika infection is uncommon in the United States). (See
         <a class="medical medical_review" href="/z/d/html/5062.html" rel="external">
          "Infants with fetal (intrauterine) growth restriction", section on 'Further evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis", section on 'Approach to testing'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis", section on 'Tests to detect Toxoplasma'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For newborns with isolated microcephaly or intracranial calcifications without an identified cause, we test for CMV and toxoplasmosis. Zika virus infection is another important consideration, depending on maternal exposures. (See
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis", section on 'Approach to testing'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2839.html" rel="external">
          "Microcephaly in infants and children: Etiology and evaluation", section on 'No syndromic features and normal development'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis", section on 'Tests to detect Toxoplasma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/109681.html" rel="external">
          "Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate", section on 'Laboratory evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For newborns with isolated SNHL, we test for CMV. (See
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis", section on 'Approach to testing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Often, symptomatic infants with congenital infections present with a combination of abnormal findings rather than a single isolated finding  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 6
         </a>
         ). Selective testing based upon the full constellation of symptoms generally has a higher yield than testing based upon a single finding.
        </p>
        <p>
         The diagnostic evaluation for specific infections is discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital toxoplasmosis (see
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis", section on 'Evaluation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital syphilis (see
         <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">
          "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis", section on 'Evaluation and diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital rubella (see
         <a class="medical medical_review" href="/z/d/html/6047.html" rel="external">
          "Congenital rubella", section on 'Evaluation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital cytomegalovirus (CMV) (see
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis", section on 'Diagnostic approach'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital HSV (see
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Evaluation and diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital varicella (see
         <a class="medical medical_review" href="/z/d/html/4969.html" rel="external">
          "Varicella-zoster infection in the newborn", section on 'Diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital enterovirus infection (see
         <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">
          "Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Laboratory diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital Zika virus infection (see
         <a class="medical medical_review" href="/z/d/html/109681.html" rel="external">
          "Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate", section on 'Evaluation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1233429063">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111578.html" rel="external">
          "Society guideline links: TORCH infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3310136">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/15831.html" rel="external">
          "Patient education: Avoiding infections in pregnancy (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topic (see
         <a class="medical medical_patient" href="/z/d/html/6717.html" rel="external">
          "Patient education: Avoiding infections in pregnancy (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H40">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          TORCH infections
         </strong>
         – The TORCH acronym (which stands for
         <strong>
          t
         </strong>
         oxoplasmosis,
         <strong>
          o
         </strong>
         ther [syphilis, varicella, Zika virus],
         <strong>
          r
         </strong>
         ubella,
         <strong>
          c
         </strong>
         ytomegalovirus, and
         <strong>
          h
         </strong>
         erpes simplex virus) is well recognized in the field of neonatal and perinatal medicine. These intrauterine and perinatal infections contribute to fetal and infant mortality, and they are important causes of childhood morbidity. Infected newborns may show abnormal growth and development in conjunction with multiple clinical and laboratory abnormalities  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 6
         </a>
         ) (see
         <a class="local">
          'Overview'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Congenital toxoplasmosis
         </strong>
         – The classic triad of congenital toxoplasmosis consists of chorioretinitis  (
         <a class="graphic graphic_picture graphicRef80549" href="/z/d/graphic/80549.html" rel="external">
          picture 2
         </a>
         ), hydrocephalus, and intracranial calcifications  (
         <a class="graphic graphic_diagnosticimage graphicRef60804" href="/z/d/graphic/60804.html" rel="external">
          image 1
         </a>
         ); signs present at birth may include fever, maculopapular rash, hepatosplenomegaly  (
         <a class="graphic graphic_picture graphicRef71515" href="/z/d/graphic/71515.html" rel="external">
          picture 1
         </a>
         ), microcephaly, seizures, jaundice, thrombocytopenia, and generalized lymphadenopathy. However, most infants with congenital toxoplasmosis are asymptomatic or without apparent abnormalities at birth. (See
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15835.html" rel="external">
          "Congenital toxoplasmosis: Treatment, outcome, and prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Congenital syphilis
         </strong>
         – Most neonates with congenital syphilis are asymptomatic at birth. Clinical manifestations after birth are divided arbitrarily into early (≤2 years of age  (
         <a class="graphic graphic_table graphicRef67809" href="/z/d/graphic/67809.html" rel="external">
          table 1
         </a>
         )) and late (&gt;2 years of age  (
         <a class="graphic graphic_table graphicRef81529" href="/z/d/graphic/81529.html" rel="external">
          table 2
         </a>
         )). (See
         <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">
          "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15400.html" rel="external">
          "Congenital syphilis: Management and outcome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Congenital varicella
         </strong>
         – Characteristic features of congenital varicella infection include cutaneous scars, cataracts, chorioretinitis, microphthalmos, nystagmus, hypoplastic limbs, cortical atrophy, and seizures. (See
         <a class="medical medical_review" href="/z/d/html/8331.html" rel="external">
          "Varicella-zoster virus infection in pregnancy", section on 'Fetal effects of VZV infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8331.html" rel="external">
          "Varicella-zoster virus infection in pregnancy", section on 'Congenital varicella syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Congenital Zika syndrome (CZS)
         </strong>
         – Clinical features of CZS include  (
         <a class="graphic graphic_picture graphicRef109690" href="/z/d/graphic/109690.html" rel="external">
          picture 3
         </a>
         ) microcephaly, facial disproportion, hypertonia/spasticity, hyperreflexia, seizures, irritability, arthrogryposis, ocular abnormalities, sensorineural hearing loss (SNHL), and neuroradiologic abnormalities (eg, intracranial calcifications, ventriculomegaly  (
         <a class="graphic graphic_diagnosticimage graphicRef109691 graphicRef109692" href="/z/d/graphic/109691.html" rel="external">
          image 2A-B
         </a>
         )). (See
         <a class="medical medical_review" href="/z/d/html/109681.html" rel="external">
          "Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Congenital rubella syndrome (CRS)
         </strong>
         – Clinical manifestations of CRS include SNHL, cataracts, cardiac malformations (eg, patent ductus arteriosus, pulmonary stenosis), low birth weight, radiolucent bone lesions, hepatosplenomegaly, jaundice, thrombocytopenia, and purpuric skin lesions (classically described as "blueberry muffin" lesions that represent extramedullary hematopoiesis). (See
         <a class="medical medical_review" href="/z/d/html/6047.html" rel="external">
          "Congenital rubella"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Congenital cytomegalovirus (CMV)
         </strong>
         – Most infants with congenital CMV infection are asymptomatic at birth. Isolated SNHL is the most common presentation and is typically identified by failed newborn hearing screen. Other clinical manifestations include petechiae, jaundice, hepatosplenomegaly, chorioretinitis, and neurologic involvement (eg, microcephaly, motor disability, cerebral calcifications  (
         <a class="graphic graphic_diagnosticimage graphicRef69239" href="/z/d/graphic/69239.html" rel="external">
          image 4
         </a>
         ), lethargy, seizures). Both asymptomatic and symptomatic infants with congenital CMV are at risk of developing late complications including late-onset SNHL, vision impairment, intellectual disability, and delay in psychomotor development. (See
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/98188.html" rel="external">
          "Congenital cytomegalovirus infection: Management and outcome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Neonatal herpes simplex virus (HSV)
         </strong>
         – Most cases of neonatal HSV infection are perinatally acquired. Affected newborns are typically healthy appearing at birth. Neonatal HSV infection usually develops in one of three patterns: localized to the skin, eyes, and mouth; localized central nervous system (CNS) disease; and disseminated disease  (
         <a class="graphic graphic_table graphicRef106132" href="/z/d/graphic/106132.html" rel="external">
          table 5
         </a>
         ). The initial manifestations of CNS disease frequently are nonspecific and include temperature abnormalities (usually fever), respiratory distress, poor feeding, and lethargy; they may progress quite rapidly to hypotension, jaundice, disseminated intravascular coagulation, apnea, and shock. Vesicular skin lesions  (
         <a class="graphic graphic_picture graphicRef75059 graphicRef56041 graphicRef78598" href="/z/d/graphic/75059.html" rel="external">
          picture 6A-C
         </a>
         )may or may not be present. (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6040.html" rel="external">
          "Neonatal herpes simplex virus infection: Management and prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Others
         </strong>
         – Other well-described causes of in utero infection include enteroviruses, varicella-zoster virus, parvovirus B19, and lymphocytic choriomeningitis virus. Thus, broadening the "other" category to include additional pathogens has been proposed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic approach
         </strong>
         – Timely diagnosis of congenital and perinatally acquired infections is crucial to the initiation of appropriate therapy. Intrauterine infection may be suspected based upon maternal laboratory results and/or clinical findings or combinations of clinical findings in the fetus or newborn (eg, hydrops fetalis, microcephaly, seizures, cataract, hearing loss, congenital heart disease, hepatosplenomegaly, jaundice, and/or rash  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 6
         </a>
         )).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Our preferred approach to testing infants with suspected congenital infection is to test only for select pathogens based upon specific clinical findings. We discourage the practice of indiscriminate screening with a battery of "TORCH titers" because such an approach is costly and has a poor diagnostic yield. (See
         <a class="local">
          'Approach to the infant with suspected intrauterine infection'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol 2015; 42:77.
          </a>
         </li>
         <li class="breakAll">
          Maldonado YA, Nizet V, Klein JO, et al. Current concepts of infections of the fetus and newborn infant. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington JS, Klein JO, Wilson CB, et al (Eds), Elsevier Saunders, Philadelphia 2011. p.2.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stamos JK, Rowley AH. Timely diagnosis of congenital infections. Pediatr Clin North Am 1994; 41:1017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kinney JS, Kumar ML. Should we expand the TORCH complex? A description of clinical and diagnostic aspects of selected old and new agents. Clin Perinatol 1988; 15:727.
          </a>
         </li>
         <li class="breakAll">
          National Newborn Screening and Genetics Resource Center. National newborn screening status report. http://genes-r-us.uthscsa.edu/nbsdisorders.pdf (Accessed on July 20, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994; 330:1858.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt DR, Hogh B, Andersen O, et al. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child 2006; 91:661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Weiden S, de Jong EP, Te Pas AB, et al. Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates? Early Hum Dev 2011; 87:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitzpatrick D, Holmes NE, Hui L. A systematic review of maternal TORCH serology as a screen for suspected fetal infection. Prenat Diagn 2022; 42:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan NA, Kazzi SN. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol 2000; 17:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cullen A, Brown S, Cafferkey M, et al. Current use of the TORCH screen in the diagnosis of congenital infection. J Infect 1998; 36:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leland D, French ML, Kleiman MB, Schreiner RL. The use of TORCH titers. Pediatrics 1983; 72:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Jong EP, Vossen AC, Walther FJ, Lopriore E. How to use... neonatal TORCH testing. Arch Dis Child Educ Pract Ed 2013; 98:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garland SM, Gilbert GL. Investigation of congenital infection--the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases. Med J Aust 1993; 159:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hwang JS, Friedlander S, Rehan VK, Zangwill KM. Diagnosis of congenital/perinatal infections by neonatologists: a national survey. J Perinatol 2019; 39:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reef SE, Plotkin S, Cordero JF, et al. Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis 2000; 31:85.
          </a>
         </li>
         <li class="breakAll">
          Cherry JD, Adachi K. Rubella virus. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2014. p.2195.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nickerson JP, Richner B, Santy K, et al. Neuroimaging of pediatric intracranial infection--part 2: TORCH, viral, fungal, and parasitic infections. J Neuroimaging 2012; 22:e52.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6011 Version 40.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25677998" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : TORCH infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25677998" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : TORCH infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7936771" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Timely diagnosis of congenital infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2850128" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Should we expand the TORCH complex? A description of clinical and diagnostic aspects of selected old and new agents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2850128" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Should we expand the TORCH complex? A description of clinical and diagnostic aspects of selected old and new agents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7818637" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16861484" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21145674" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34893980" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : A systematic review of maternal TORCH serology as a screen for suspected fetal infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11012137" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Yield and costs of screening growth-retarded infants for torch infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9570652" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Current use of the TORCH screen in the diagnosis of congenital infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6306545" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The use of TORCH titers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23470252" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : How to use... neonatal TORCH testing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8395645" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Investigation of congenital infection--the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30914779" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Diagnosis of congenital/perinatal infections by neonatologists: a national survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10913402" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10913402" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22309611" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Neuroimaging of pediatric intracranial infection--part 2: TORCH, viral, fungal, and parasitic infections.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
